文献速递脑血管病

111万例缺血性卒中治疗的年龄与性别差异:德国全国分析

Age and Sex Differences in Ischemic Stroke Treatment in a Nationwide Analysis of 1.11 Million Hospitalized Cases.
PubMed 文献 · Stroke · 2019-10-18

结果显示卒中单元治疗、IVT和MT使用率均显著上升,但≥80岁患者仍较少接受治疗;男性卒中单元治疗概率更高且院内死亡率更低,IVT无性别差异,而女性各年龄段接受MT更多。

要点

  • 2013至2017年德国卒中单元治疗、IVT和MT使用率均显著上升。
  • ≥80岁患者接受卒中单元治疗、IVT和MT仍显著少于年轻患者。
  • 男性卒中单元治疗概率更高且院内死亡率更低,IVT无性别差异。

核心结论

  • 需增加老年患者和所有年龄段女性获得卒中单元治疗的机会。
  • IVT使用无性别差异,但女性各年龄段MT使用显著更高,需进一步研究。

研究设计与样本

  • 患者按6个预设年龄组(20-44、45-59、60-69、70-79、80-89、>90岁)分层,采用随机效应模型计算合并估计值,并以OR及95%CI评估性别差异。

主要发现

  • 卒中单元治疗从2013年66.8%增至2017年73.5%,IVT从12.4%增至15.9%,MT从2.4%增至5.8%(均P<0.001)。
  • 尽管差异随时间缩小,≥80岁患者仍显著较少接受治疗。
  • 男性所有年龄组接受卒中单元治疗的概率显著更高(OR 1.11;95%CI 1.09-1.12),院内死亡率更低(OR 0.91;95%CI 0.89-0.93)。
  • IVT使用无性别差异(OR 1.00;95%CI 0.98-1.01)。
  • 女性所有年龄段接受MT治疗更频繁(OR 1.26;95%CI 1.22-1.30)。

临床怎么用

  • 临床应关注老年(≥80岁)缺血性卒中患者治疗可及性,并减少女性卒中单元治疗获取障碍。
  • IVT使用无需按性别区别对待,但女性MT使用率较高需进一步探究原因。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Background and Purpose- To date, there is still uncertainty about age and sex differences in access to stroke unit treatment and use of intravenous thrombolysis (IVT), while age and sex differences have not been investigated for the new treatment option of mechanical thrombectomy (MT). We, therefore, undertook a complete nationwide analysis of all hospitalized ischemic stroke patients in Germany from 2013 to 2017. Methods- We used the nationwide administrative database of the German Federal Statistical Office and investigated access to stroke unit treatment, IVT, MT, and in-hospital mortality. Patients were subdivided into 6 predefined age groups (20-44, 45-59, 60-69, 70-79, 80-89, and >90 years). Pooled overall and age group estimates were calculated using the random-effects model. To evaluate potential sex disparities, we estimated odds ratios (ORs) with 95% CIs. Results- A total of 1 112 570 patients were hospitalized for first or recurrent ischemic stroke from 2013 to 2017. Overall, stroke unit treatment increased significantly from 66.8% in 2013 to 73.5% in 2017, as did IVT (from 12.4% to 15.9%) and MT (from 2.4% to 5.8%; all P<0.001). Although the difference became smaller over time, patients ≥80 years of age still received significantly less often treatments. Men of all age groups had a significantly higher probability receiving stroke unit treatment (OR, 1.11; 95% CI, 1.09-1.12) and lower in-hospital mortality (OR, 0.91; 95% CI, 0.89-0.93). No disparity was observed in the use of IVT (OR, 1.00; 95% CI, 0.98-1.01), while women of all ages were treated more often with MT (OR, 1.26; 95% CI, 1.22-1.30). Conclusions- Access to stroke unit treatment has to be increased in both older patients and women of all ages. While there was no sex difference in IVT use, it is important to further investigate the significantly higher frequency of MT in women with ischemic stroke irrespective of age.

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. Weber R, Krogias C, Eyding J, et al. Age and Sex Differences in Ischemic Stroke Treatment in a Nationwide Analysis of 1.11 Million Hospitalized Cases. Stroke. 2019. PMID: 31623547. doi:10.1161/STROKEAHA.119.026723

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。